These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 19252156)

  • 1. Differential efficacy of escitalopram and nortriptyline on dimensional measures of depression.
    Uher R; Maier W; Hauser J; Marusic A; Schmael C; Mors O; Henigsberg N; Souery D; Placentino A; Rietschel M; Zobel A; Dmitrzak-Weglarz M; Petrovic A; Jorgensen L; Kalember P; Giovannini C; Barreto M; Elkin A; Landau S; Farmer A; Aitchison KJ; McGuffin P
    Br J Psychiatry; 2009 Mar; 194(3):252-9. PubMed ID: 19252156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melancholic, atypical and anxious depression subtypes and outcome of treatment with escitalopram and nortriptyline.
    Uher R; Dernovsek MZ; Mors O; Hauser J; Souery D; Zobel A; Maier W; Henigsberg N; Kalember P; Rietschel M; Placentino A; Mendlewicz J; Aitchison KJ; McGuffin P; Farmer A
    J Affect Disord; 2011 Jul; 132(1-2):112-20. PubMed ID: 21411156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suicidal ideation during treatment of depression with escitalopram and nortriptyline in genome-based therapeutic drugs for depression (GENDEP): a clinical trial.
    Perroud N; Uher R; Marusic A; Rietschel M; Mors O; Henigsberg N; Hauser J; Maier W; Souery D; Placentino A; Szczepankiewicz A; Jorgensen L; Strohmaier J; Zobel A; Giovannini C; Elkin A; Gunasinghe C; Gray J; Campbell D; Gupta B; Farmer AE; McGuffin P; Aitchison KJ
    BMC Med; 2009 Oct; 7():60. PubMed ID: 19832967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the effects of escitalopram and nortriptyline on painful symptoms in patients with major depression.
    Jaracz J; Gattner K; Moczko J; Hauser J
    Gen Hosp Psychiatry; 2015; 37(1):36-9. PubMed ID: 25480462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An inflammatory biomarker as a differential predictor of outcome of depression treatment with escitalopram and nortriptyline.
    Uher R; Tansey KE; Dew T; Maier W; Mors O; Hauser J; Dernovsek MZ; Henigsberg N; Souery D; Farmer A; McGuffin P
    Am J Psychiatry; 2014 Dec; 171(12):1278-86. PubMed ID: 25017001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential change on depressive symptom factors with antidepressant medication and cognitive behavior therapy for major depressive disorder.
    Dunlop BW; Cole SP; Nemeroff CB; Mayberg HS; Craighead WE
    J Affect Disord; 2018 Mar; 229():111-119. PubMed ID: 29306690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of antidepressant switching between nortriptyline and escitalopram after a failed first antidepressant treatment among patients with major depressive disorder.
    Köhler-Forsberg O; Larsen ER; Buttenschøn HN; Rietschel M; Hauser J; Souery D; Maier W; Farmer A; McGuffin P; Aitchison KJ; Uher R; Mors O
    Br J Psychiatry; 2019 Aug; 215(2):494-501. PubMed ID: 30698114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sexual dysfunction during treatment with serotonergic and noradrenergic antidepressants: clinical description and the role of the 5-HTTLPR.
    Strohmaier J; Wüst S; Uher R; Henigsberg N; Mors O; Hauser J; Souery D; Zobel A; Dernovsek MZ; Streit F; Schmäl C; Kozel D; Placentino A; Farmer A; McGuffin P; Aitchison KJ; Rietschel M
    World J Biol Psychiatry; 2011 Oct; 12(7):528-38. PubMed ID: 21388237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-random dropout and the relative efficacy of escitalopram and nortriptyline in treating major depressive disorder.
    Power RA; Muthén B; Henigsberg N; Mors O; Placentino A; Mendlewicz J; Maier W; McGuffin P; Lewis CM; Uher R
    J Psychiatr Res; 2012 Oct; 46(10):1333-8. PubMed ID: 22770672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early and delayed onset of response to antidepressants in individual trajectories of change during treatment of major depression: a secondary analysis of data from the Genome-Based Therapeutic Drugs for Depression (GENDEP) study.
    Uher R; Mors O; Rietschel M; Rajewska-Rager A; Petrovic A; Zobel A; Henigsberg N; Mendlewicz J; Aitchison KJ; Farmer A; McGuffin P
    J Clin Psychiatry; 2011 Nov; 72(11):1478-84. PubMed ID: 22127194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in body weight during pharmacological treatment of depression.
    Uher R; Mors O; Hauser J; Rietschel M; Maier W; Kozel D; Henigsberg N; Souery D; Placentino A; Keers R; Gray JM; Dernovsek MZ; Strohmaier J; Larsen ER; Zobel A; Szczepankiewicz A; Kalember P; Mendlewicz J; Aitchison KJ; McGuffin P; Farmer A
    Int J Neuropsychopharmacol; 2011 Apr; 14(3):367-75. PubMed ID: 20716398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Association between polymorphisms of ins/del in the 5-HTT gene and T102C in the 5HTR2A gene and the drug response for escitalopram and nortriptyline in depressed patients].
    Rajewska-Rager A; Dmitrzak-Weglarz M; Kapelski P; Skibińska M; Kaczmarkiewicz-Fass M; Hauser J
    Psychiatr Pol; 2008; 42(6):903-14. PubMed ID: 19441667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome-wide pharmacogenetics of antidepressant response in the GENDEP project.
    Uher R; Perroud N; Ng MY; Hauser J; Henigsberg N; Maier W; Mors O; Placentino A; Rietschel M; Souery D; Zagar T; Czerski PM; Jerman B; Larsen ER; Schulze TG; Zobel A; Cohen-Woods S; Pirlo K; Butler AW; Muglia P; Barnes MR; Lathrop M; Farmer A; Breen G; Aitchison KJ; Craig I; Lewis CM; McGuffin P
    Am J Psychiatry; 2010 May; 167(5):555-64. PubMed ID: 20360315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baseline severity of depression predicts antidepressant drug response relative to escitalopram.
    Kilts CD; Wade AG; Andersen HF; Schlaepfer TE
    Expert Opin Pharmacother; 2009 Apr; 10(6):927-36. PubMed ID: 19317630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse reactions to antidepressants.
    Uher R; Farmer A; Henigsberg N; Rietschel M; Mors O; Maier W; Kozel D; Hauser J; Souery D; Placentino A; Strohmaier J; Perroud N; Zobel A; Rajewska-Rager A; Dernovsek MZ; Larsen ER; Kalember P; Giovannini C; Barreto M; McGuffin P; Aitchison KJ
    Br J Psychiatry; 2009 Sep; 195(3):202-10. PubMed ID: 19721108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single i.v. ketamine augmentation of newly initiated escitalopram for major depression: results from a randomized, placebo-controlled 4-week study.
    Hu YD; Xiang YT; Fang JX; Zu S; Sha S; Shi H; Ungvari GS; Correll CU; Chiu HF; Xue Y; Tian TF; Wu AS; Ma X; Wang G
    Psychol Med; 2016 Feb; 46(3):623-35. PubMed ID: 26478208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relapse Prevention in Major Depressive Disorder After Successful Acute Electroconvulsive Treatment: a 6-month Double-blind Comparison of Three Fixed Dosages of Escitalopram and a Fixed Dose of Nortriptyline - Lessons from a Failed Randomised Trial of the Danish University Antidepressant Group (DUAG-7).
    Martiny K; Larsen ER; Licht RW; Nielsen CT; Damkier P; Refsgaard E; Lunde M; Straasø B; Christensen EM; Lolk A; Holmskov J; Sørensen CH; Brødsgaard I; Eftekhari SZ; Bendsen BB; Klysner R; Terp IM; Larsen JK; Vestergaard P; Buchholtz PE; Gram LF; Bech P;
    Pharmacopsychiatry; 2015 Nov; 48(7):274-8. PubMed ID: 26529118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Association between polymorphisms of Val66Met in the BDNF gene and the response to escitalopram and nortriptyline treatment in the light of the neurodevelopmental hypothesis of depression].
    Rajewska-Rager A; Skibińska M; Szczepankiewicz A; Kapelski P; Dmitrzak-Weglarz M; Leszczyńska-Rodziewicz A; Hauser J
    Psychiatr Pol; 2008; 42(6):915-23. PubMed ID: 19441668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Escitalopram continuation treatment prevents relapse of depressive episodes.
    Rapaport MH; Bose A; Zheng H
    J Clin Psychiatry; 2004 Jan; 65(1):44-9. PubMed ID: 14744167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Open-label treatment with desvenlafaxine in postmenopausal women with major depressive disorder not responding to acute treatment with desvenlafaxine or escitalopram.
    Soares CN; Thase ME; Clayton A; Guico-Pabia CJ; Focht K; Jiang Q; Kornstein SG; Ninan PT; Kane CP
    CNS Drugs; 2011 Mar; 25(3):227-38. PubMed ID: 21323394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.